American Cannabis Company, Inc. Logo

American Cannabis Company, Inc.

AMMJ

(1.2)
Stock Price

0,00 USD

-202.97% ROA

-492.48% ROE

-0.15x PER

Market Cap.

1.059.066,00 USD

-850.31% DER

0% Yield

-168.87% NPM

American Cannabis Company, Inc. Stock Analysis

American Cannabis Company, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

American Cannabis Company, Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's PBV ratio (1.09x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

2 DER

The stock has a reasonable amount of debt compared to its ownership (97%), suggesting a balanced financial position and a moderate level of risk.

3 Revenue Growth

Over the past three years, this company's revenue has consistently grown, demonstrating a positive financial trend that makes it an appealing choice.

4 Net Profit Growth

Throughout the last three years, this company has experienced consistent net profit growth, reflecting a robust financial performance and making it an attractive investment prospect.

5 Graham Number

The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.

6 ROE

The stock's ROE indicates a negative return (-29.56%) on shareholders' equity, suggesting poor financial performance.

7 ROA

The stock's ROA (-22.67%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (-1), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

American Cannabis Company, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

American Cannabis Company, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

American Cannabis Company, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

American Cannabis Company, Inc. Revenue
Year Revenue Growth
1997 170.000
1998 70.000 -142.86%
1999 70.000 0%
2000 91.929 23.85%
2001 21.378 -330.02%
2002 1.154.736 98.15%
2003 473.848 -143.69%
2004 91.892 -415.66%
2005 71.355 -28.78%
2006 51.402 -38.82%
2007 285.234 81.98%
2008 1.700.200 83.22%
2009 1.700.200 0%
2010 0 0%
2011 0 0%
2012 3.949.624 100%
2013 7.767.779 49.15%
2014 1.259.012 -516.97%
2015 2.799.887 55.03%
2016 1.560.866 -79.38%
2017 2.443.054 36.11%
2018 982.348 -148.7%
2019 2.130.735 53.9%
2020 1.569.794 -35.73%
2021 2.425.204 35.27%
2022 18.808.545 87.11%
2023 2.399.560 -683.83%
2023 2.476.185 3.09%
2024 1.023.284 -141.98%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

American Cannabis Company, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1997 80.000
1998 60.000 -33.33%
1999 20.000 -200%
2000 64.564 69.02%
2001 3.848 -1577.86%
2002 9.756 60.56%
2003 8.750 -11.5%
2004 2.677 -226.86%
2005 352 -660.51%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 12.863 100%
2015 51.115 74.84%
2016 2.553 -1902.15%
2017 2.403 -6.24%
2018 590 -307.29%
2019 347 -70.03%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

American Cannabis Company, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1997 680.000
1998 670.000 -1.49%
1999 580.000 -15.52%
2000 0 0%
2001 0 0%
2002 2.809.637 100%
2003 1.850.939 -51.8%
2004 851.309 -117.42%
2005 733.260 -16.1%
2006 0 0%
2007 0 0%
2008 0 0%
2009 37.550 100%
2010 9.061 -314.41%
2011 18.737 51.64%
2012 733.850 97.45%
2013 5.021.094 85.38%
2014 3.675.313 -36.62%
2015 687.082 -434.92%
2016 1.311.668 47.62%
2017 1.971.300 33.46%
2018 963.019 -104.7%
2019 1.122.582 14.21%
2020 1.040.872 -7.85%
2021 2.092.478 50.26%
2022 2.911.482 28.13%
2023 1.305.716 -122.98%
2023 3.385.519 61.43%
2024 928.536 -264.61%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

American Cannabis Company, Inc. EBITDA
Year EBITDA Growth
1997 -2.100.000
1998 -670.000 -213.43%
1999 -1.410.000 52.48%
2000 35.132 4113.44%
2001 -881.706 103.98%
2002 -2.806.113 68.58%
2003 -1.878.763 -49.36%
2004 -1.900.646 1.15%
2005 -1.282.564 -48.19%
2006 -773.949 -65.72%
2007 -1.513.363 48.86%
2008 2.013.497 175.16%
2009 -90.846 2316.38%
2010 -376.632 75.88%
2011 -34.298 -998.12%
2012 413.420 108.3%
2013 -3.969.109 110.42%
2014 -3.424.727 -15.9%
2015 -622.162 -450.46%
2016 -527.810 -17.88%
2017 195.621 369.81%
2018 -586.833 133.34%
2019 153.979 481.11%
2020 -511.780 130.09%
2021 -1.104.853 53.68%
2022 -322.135 -242.98%
2023 -276.876 -16.35%
2023 -2.277.260 87.84%
2024 -214.072 -963.78%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

American Cannabis Company, Inc. Gross Profit
Year Gross Profit Growth
1997 40.000
1998 20.000 -100%
1999 30.000 33.33%
2000 51.030 41.21%
2001 -34.759 246.81%
2002 814.542 104.27%
2003 246.756 -230.1%
2004 -103.667 338.03%
2005 58.231 278.03%
2006 45.424 -28.19%
2007 245.242 81.48%
2008 1.700.200 85.58%
2009 1.700.200 0%
2010 0 0%
2011 0 0%
2012 1.430.644 100%
2013 1.100.333 -30.02%
2014 487.536 -125.69%
2015 799.774 39.04%
2016 869.285 8%
2017 1.637.234 46.91%
2018 458.501 -257.08%
2019 1.338.952 65.76%
2020 720.679 -85.79%
2021 1.056.148 31.76%
2022 2.537.214 58.37%
2023 994.944 -155.01%
2023 1.041.883 4.51%
2024 423.180 -146.2%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

American Cannabis Company, Inc. Net Profit
Year Net Profit Growth
1997 -2.920.000
1998 -710.000 -311.27%
1999 -1.770.000 59.89%
2000 -2.089.119 15.28%
2001 -2.966.093 29.57%
2002 -3.221.096 7.92%
2003 -2.045.661 -57.46%
2004 -313.421 -552.69%
2005 -363.972 13.89%
2006 -788.282 53.83%
2007 -2.300.308 65.73%
2008 -45.165 -4993.12%
2009 -526.212 91.42%
2010 102.718 612.29%
2011 -214.588 147.87%
2012 -329.260 34.83%
2013 -4.500.294 92.68%
2014 -3.619.192 -24.35%
2015 -515.653 -601.87%
2016 -603.682 14.58%
2017 -1.488.474 59.44%
2018 -950.691 -56.57%
2019 -542.397 -75.28%
2020 -627.612 13.58%
2021 -1.550.506 59.52%
2022 -638.630 -142.79%
2023 -628.632 -1.59%
2023 -3.660.416 82.83%
2024 -530.204 -590.38%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

American Cannabis Company, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1997 0
1998 0 0%
1999 0 0%
2000 -849 100%
2001 -762 -11.56%
2002 -477 -59.87%
2003 -165 -190.24%
2004 -23 -613.04%
2005 -26 11.54%
2006 -54 51.85%
2007 -60 10%
2008 0 0%
2009 -2 100%
2010 0 0%
2011 -1 0%
2012 -4 100%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

American Cannabis Company, Inc. Free Cashflow
Year Free Cashflow Growth
1997 -430.000
1998 -420.000 -2.38%
1999 -570.000 26.32%
2000 -1.062.868 46.37%
2001 -741.615 -43.32%
2002 -2.526.251 70.64%
2003 -592.816 -326.14%
2004 -1.178.855 49.71%
2005 -345.579 -241.12%
2006 -360.456 4.13%
2007 -1.530.065 76.44%
2008 -857.361 -78.46%
2009 -78.455 -992.81%
2010 -441 -17690.25%
2011 -214.588 99.79%
2011 -214.588 0%
2012 -202.577 -5.93%
2013 7.411 2833.46%
2014 26.385 71.91%
2015 140.567 81.23%
2016 -788.239 117.83%
2017 175.912 548.09%
2018 -561.522 131.33%
2019 -141.384 -297.16%
2020 -528.027 73.22%
2021 -1.323.938 60.12%
2022 -302.640 -337.46%
2023 -81.895 -269.55%
2023 -159.186 48.55%
2024 -11.289 -1310.1%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

American Cannabis Company, Inc. Operating Cashflow
Year Operating Cashflow Growth
1997 -410.000
1998 -420.000 2.38%
1999 -550.000 23.64%
2000 -1.058.301 48.03%
2001 -730.129 -44.95%
2002 -2.502.704 70.83%
2003 -592.816 -322.17%
2004 -1.177.248 49.64%
2005 -339.551 -246.71%
2006 -360.456 5.8%
2007 -1.489.923 75.81%
2008 -857.361 -73.78%
2009 -78.455 -992.81%
2010 -441 -17690.25%
2011 -214.588 99.79%
2011 -214.588 0%
2012 -194.127 -10.54%
2013 55.217 451.57%
2014 74.113 25.5%
2015 149.225 50.33%
2016 -784.879 119.01%
2017 180.541 534.74%
2018 -561.522 132.15%
2019 -102.848 -445.97%
2020 -525.794 80.44%
2021 -957.978 45.11%
2022 -198.965 -381.48%
2023 -42.792 -364.96%
2023 -159.186 73.12%
2024 -11.289 -1310.1%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

American Cannabis Company, Inc. Capital Expenditure
Year Capital Expenditure Growth
1997 20.000
1998 0 0%
1999 20.000 100%
2000 4.567 -337.92%
2001 11.486 60.24%
2002 23.547 51.22%
2003 0 0%
2004 1.607 100%
2005 6.028 73.34%
2006 0 0%
2007 40.142 100%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2011 0 0%
2012 8.450 100%
2013 47.806 82.32%
2014 47.728 -0.16%
2015 8.658 -451.26%
2016 3.360 -157.68%
2017 4.629 27.41%
2018 0 0%
2019 38.536 100%
2020 2.233 -1625.75%
2021 365.960 99.39%
2022 103.675 -252.99%
2023 39.103 -165.13%
2023 0 0%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

American Cannabis Company, Inc. Equity
Year Equity Growth
1997 2.120.000
1998 2.010.000 -5.47%
1999 1.290.000 -55.81%
2000 391.699 -229.33%
2001 -1.555.253 125.19%
2002 -1.159.281 -34.16%
2003 -4.240.534 72.66%
2004 -4.215.135 -0.6%
2005 -3.663.967 -15.04%
2006 -4.216.760 13.11%
2007 -5.704.390 26.08%
2008 -5.490.808 -3.89%
2009 -2.912.881 -88.5%
2010 -2.810.164 -3.66%
2011 -3.024.752 7.09%
2011 -3.024.752 0%
2012 -67.514 -4380.18%
2013 -1.205.628 94.4%
2014 84.359 1529.16%
2015 137.890 38.82%
2016 654.934 78.95%
2017 781.455 16.19%
2018 1.005.321 22.27%
2019 879.594 -14.29%
2020 1.627.187 45.94%
2021 2.118.981 23.21%
2022 1.869.622 -13.34%
2023 1.550 -120520.77%
2023 1.365.649 99.89%
2024 -131.001 1142.47%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

American Cannabis Company, Inc. Assets
Year Assets Growth
1997 3.130.000
1998 3.040.000 -2.96%
1999 2.870.000 -5.92%
2000 1.368.956 -109.65%
2001 443.312 -208.8%
2002 1.530.367 71.03%
2003 655.790 -133.36%
2004 377.309 -73.81%
2005 427.717 11.79%
2006 520.399 17.81%
2007 447.526 -16.28%
2008 11.396 -3827.04%
2009 79.888 85.74%
2010 0 0%
2011 0 0%
2011 2.000 100%
2012 1.147.842 99.83%
2013 733.756 -56.43%
2014 470.092 -56.09%
2015 730.910 35.68%
2016 983.953 25.72%
2017 1.858.256 47.05%
2018 1.275.369 -45.7%
2019 1.203.953 -5.93%
2020 1.888.341 36.24%
2021 4.223.199 55.29%
2022 4.616.201 8.51%
2023 2.829.083 -63.17%
2023 4.169.072 32.14%
2024 2.628.487 -58.61%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

American Cannabis Company, Inc. Liabilities
Year Liabilities Growth
1997 1.020.000
1998 1.040.000 1.92%
1999 1.590.000 34.59%
2000 977.257 -62.7%
2001 1.998.565 51.1%
2002 2.689.648 25.69%
2003 4.896.324 45.07%
2004 4.592.444 -6.62%
2005 4.091.684 -12.24%
2006 4.737.159 13.63%
2007 6.151.916 23%
2008 5.502.204 -11.81%
2009 2.992.769 -83.85%
2010 2.810.164 -6.5%
2011 3.024.752 7.09%
2011 3.024.752 0%
2012 1.215.356 -148.88%
2013 1.939.384 37.33%
2014 385.733 -402.78%
2015 593.020 34.95%
2016 329.019 -80.24%
2017 1.076.801 69.44%
2018 270.048 -298.74%
2019 324.359 16.74%
2020 261.154 -24.2%
2021 2.104.218 87.59%
2022 2.746.579 23.39%
2023 2.827.533 2.86%
2023 2.803.423 -0.86%
2024 2.759.488 -1.59%

American Cannabis Company, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.02
Net Income per Share
-0.04
Price to Earning Ratio
-0.15x
Price To Sales Ratio
0.53x
POCF Ratio
3.16
PFCF Ratio
6.86
Price to Book Ratio
-3.73
EV to Sales
1.09
EV Over EBITDA
-1.2
EV to Operating CashFlow
14
EV to FreeCashFlow
14
Earnings Yield
-6.88
FreeCashFlow Yield
0.15
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0.04
Graham NetNet
-0.03

Income Statement Metrics

Net Income per Share
-0.04
Income Quality
-0.05
ROE
-4.92
Return On Assets
-1.28
Return On Capital Employed
-4.71
Net Income per EBT
1
EBT Per Ebit
1.5
Ebit per Revenue
-1.12
Effective Tax Rate
-0.07

Margins

Sales, General, & Administrative to Revenue
1.49
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.88
Gross Profit Margin
0.42
Operating Profit Margin
-1.12
Pretax Profit Margin
-1.69
Net Profit Margin
-1.69

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
-2.44
Return on Tangible Assets
-2.03
Days Sales Outstanding
22.15
Days Payables Outstanding
340.12
Days of Inventory on Hand
212.92
Receivables Turnover
16.48
Payables Turnover
1.07
Inventory Turnover
1.71
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
-0.01
Shareholders Equity per Share
-0
Interest Debt per Share
0.01
Debt to Equity
-8.5
Debt to Assets
0.42
Net Debt to EBITDA
-0.61
Current Ratio
0.38
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
468436
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.37
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
628066
Debt to Market Cap
1.05

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

American Cannabis Company, Inc. Dividends
Year Dividends Growth

American Cannabis Company, Inc. Profile

About American Cannabis Company, Inc.

American Cannabis Company, Inc., together with its subsidiary, Hollister & Blacksmith, Inc., provides solutions for businesses operating in the regulated cannabis industry in the United States and Canada. The company offers consulting services for companies associated with the cannabis and hemp industries in various stages of development, such as cannabis and hemp business planning, license applications, growth strategies, and monitoring, as well as cultivation build-out oversight services, cannabis regulatory compliance, and compliance audit services. It also sells products and equipment used in the cultivation, processing, transportation, or retail sale of cannabis, such as The Satchel, a pouch-like case designed as a child-proof exit package solution for the regulated cannabis industry; SoHum Living Soil, a just-add-water soil; High Density Cultivation System, which ensures that space is used in an efficient manner; The Cultivation Cube, a self-contained and scalable cultivation system; and other products for cultivation operations, medicinal and recreational cannabis dispensary operations, and infused-products. In addition, the company offers advisory and consulting services specific to design industry-specific products and facilities, and manage a strategic group partnership that offers customer products commonly used in the industry. American Cannabis Company, Inc. was founded in 2013 and is headquartered in Denver, Colorado.

CEO
Mr. Ellis Lamar Smith
Employee
4
Address
2590 Walnut Street
Denver, 80205

American Cannabis Company, Inc. Executives & BODs

American Cannabis Company, Inc. Executives & BODs
# Name Age
1 Mr. Ellis Lamar Smith
Co-Founder, Chief Executive Officer, Chief Financial Officer & Chairman
70
2 Mr. Jon Workman
Vice President of Sales
70

American Cannabis Company, Inc. Competitors